Myocardial Infarction Due to Percutaneous Coronary Intervention  

Oleh:

Prasad, Abhiram ; Herrmann, Joerg

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 364 no. 05 (Feb. 2011), page 453-464.
Topik: Periprocedural Myocardial Infarction; Percutaneous Coronary Intervention; PCI

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2011.01 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Approximately 1.5 million patients undergo percutaneous coronary intervention (PCI) in the United States every year.1 Depending on local practices and the diagnostic criteria used, 5 to 30% of these patients (75,000 to 450,000) have evidence of a periprocedural myocardial infarction.2,3 At the higher estimate, the incidence of these events is similar to the annual rate of major spontaneous myocardial infarction.1 Thus, many cardiologists and internists are likely to encounter patients with coronary artery disease who have sustained a periprocedural myocardial infarction. However, the clinical significance of these events and their management remain a matter of considerable controversy and uncertainty. Questions that often arise include the following: Do we need to routinely screen patients for periprocedural myocardial infarction? Which patients should be observed in the hospital for a prolonged period after periprocedural myocardial infarction? What are the therapeutic implications, and what should we tell patients who sustained a periprocedural myocardial infarction despite an otherwise successful procedure? Is a periprocedural myocardial infarction prognostically equivalent to a spontaneous myocardial infarction? Is periprocedural myocardial infarction a valid end point in clinical trials? The aim of this review is to address these questions and to provide a current perspective on this issue.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali